ACETAM Acetaminophen Abbott AxSym 3 SD 4 CAP ACETAM Acetaminophen 2.5 mg/mL or 25% 6 AAB ACETAM Acetaminophen 20% 8 CFX ACETONE Acetone 25% 2 WLSH ACID PHOS Acid Phos(Pros) 1.5 U/L & ug/L, 15% 7 RCPA ACID PHOS Acid Phos(Total) 1.5 U/L & ug/L, 15% 7 RCPA ACID PHOS Acid phosphatase S- 10.3% 5 BV ACID PHOS Acid phosphatase tartrate resistent S- 13.2% 5 BV ACMV Anti-CMV Positive or Negative 3 NYS ACRAT A/C Ratio 2.5 SD 2 WLSH ACT Activated Clotting Time (ACT) 2 SD 2 WLSH ACT Activated Clotting Time 20% 6 AAB ACTH ACTH 2.0 pmol/L, 10% 7 RCPA ADENOSINE Adenosine S- 16.7% 5 BV
ALCOHOL Alcohol 2.2 mmol/L, 10% 7 RCPA ALCOHOL Ethanol 15% 8 CFX ALD Aldosterone 75.0 pmol/L, 15% 7 RCPA ALD Aldosterone S- 36.7% 5 BV ALD Aldosterone, concentration U- 39.6% 5 BV ALKP Alkaline phosphatase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB ALKP Alk Phos AU640 30% 4 CAP ALKP Alkaline Phosphatase 30% 6 AAB ALKP Alkaline Phosphatase 15 U/L, 15% 7 RCPA ALKP Alkaline Phosphatase 30% 8 CFX ALKP Alkaline phosphatase S- 11.7% 5 BV ALKP Alkaline phosphatase, bone isoform S- 14.5% 5 BV ALT Alanine aminotransferase (ALT, SGPT) +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB ALT ALT AU640 20% 4 CAP ALT Alanine 20% 6 AAB
AMPHET Amphetamines, qualitative Presence or Absence 3 NYS AMPHET Amphetamine Abbott AxSym 80% consensus 4 CAP AMY Amylase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB AMY Amylase AU640 30% 4 CAP AMY Amylase 15 U/L, 15% 7 RCPA AMY Amylase 20% 8 CFX AMY a-Amylase S- 15.7% 5 BV AMY a-Amylase (pancreatic) S- 17.7% 5 BV AMY Amylase -urine U- 30% 2 WLSH AMY Amylase, urine U- AU640 3 SD 4 CAP AMY a-Amylase concentration, random U- 103.7% 5 BV ANA Antinuclear antibody Target value +/- 2 dilution or (pos. or neg.) 1 CLIA, 3 NYS AND Androstenedione 2.0 nmol/L 7 RCPA AND Androstendione S- 22.6% 5 BV ANTIDEPRESS Tricyclic Pos/Neg 2 WLSH
Antidepressants ANTIDEPRESS Tricyclic Antidepressants 20% or 2 SD 3 NYS ANTIDEPRESS Tricyclic Antidepressants 10 nmol/L, 10% 7 RCPA ANTIDEPRESS Tricyclic Antidepressants 15% 8 CFX ANTITHROM Antithrombin III P- 8.3% 5 BV APOA1 Apolipoprotein A1 BNII 3 SD 4 CAP APOA1 Apolipoprotein A1 25 mg/dL or 30% 6 AAB APOA1 Apolipoprotein A1 0.2 g/L, 10% 7 RCPA APOA1 Apolipoprotein AI 10% 8 CFX APOA1 Apolipoprotein A1 S- 9.1% 5 BV APOB Apolipoprotein b BNII 3 SD 4 CAP APOB Apolipoprotein B100 BNII not evaluated 4 CAP APOB Apolipoprotein B 20 mg/dL or 25% 6 AAB APOB Apolipoprotein B 0.2 g/L, 10% 7 RCPA APOB Apolipoprotein B 12% 8 CFX APOB Apolipoprotein B S- 11.6% 5 BV APTT Partial +/- 15% 1 CLIA, 2 WLSH, 3 NYS,
CALCIT Calcitonin 2 ng/L, 10% 7 RCPA CARBAM Carbamazepine +/- 25% 1 CLIA, 2 WLSH, 6 AAB CARBAM Carbamazepine +/- 15% 3 NYS CARBAM Carbamazepine Abbott AxSym 25% 4 CAP CARBAM Carbamazepine, free TDX 3 SD 4 CAP CARBAM Carbamazepine 2.0 umol/L, 10% 7 RCPA CARBAM Carbamazepine 25% 8 CFX CARBOXY Carboxyhemoglobin 3 SD 2 WLSH CARBOXY Carboxyhemoglobin 725 3 SD 4 CAP CARBOXY Fractional Carboxyhemoglobin 0.02 7 RCPA CARCINOEMB Carcinoembryonic Antigen 1.2 ng/mL or 30% 6 AAB CARCINOEMB Carcinoembryonic antigen S- 21.8% 5 BV CAROT Total Carotenoids 0.4 umol/L, 10% 7 RCPA
GH Growth Hormone 2 mU/L, 20% 7 RCPA GLOB Beta 2 microglobulin 0.06 mg/L or 30% 6 AAB GLOB Beta-2 Microglobulin 0.2 mg/L, 10% 7 RCPA GLOB a1-Globulins S- 15.7% 5 BV GLOB a2-Globulins S- 12.6% 5 BV GLOB b-Globulins S- 11.7% 5 BV GLOB b2-Microglobulin S- 9% 5 BV GLOB g-Globulins S- 16.8% 5 BV GLOB Globulins, total S- 8% 5 BV GLU Glucose +/- 6 mg/dL or +/- 10% (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB GLU Glucose, CSF 10% 2 WLSH GLU Glucose, Whole Blood 20 mg/dL or 20% 2 WLSH GLU Glucose, Urine (qual) 80% Agreement 3 NYS GLU Glucose AU640 10% or 6 mg/dL (greater) 4 CAP GLU Glucose 725 10% or 6 mg/dL (greater) 4 CAP GLU Glucose, Urine AU640 10% or 6 g/24 hs (greater) 4 CAP GLU Whole Blood 6 mg/dL or 10% 6 AAB
HEPAT Hepatitis (HBsAg, anti-HBc, HBeAg) Reactive (positive) or nonreactive (negative) 1 CLIA HEPAT Hepatitis (Anti-HBc HBsAg HBeAg ) Reactive (Positive) or Nonreactive (Negative) 3 NYS HETEROPHILE Heterophile Positive or Negative or +/- 2 dilutions 3 NYS HGB Hemoglobin +/- 7% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB HGB Hemoglobin,total 7% 2 WLSH HGB Hemoglobin, Urine (qual) 80% Agreement 3 NYS HGB Hemoglobin concentration 3 g/L, 3% 7 RCPA HGB Hemoglobin B- 4.1% 5 BV HIDROX concentration, 2 U- 26.5% 5 BV HMMA HMMA 20 umol/day, 20% 7 RCPA HOMOCY Homocysteine Non-graded analyte 3 NYS HOMOCY Homocysteine IMX 3 SD 4 CAP HOMOCY Homocysteine 2.5 umol/L or 20% 6 AAB
LDH Lactate (LDH) +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB LDH Lactate Dehydrogenase AU640 20% 4 CAP LDH Lactate Dehydrogenase 20% 6 AAB LDH Lactate Dehydrogenase 30 U/L, 15% 7 RCPA LDH Lactate Dehydrogenase 20% 8 CFX LDH Lactate dehydrogenase (LDH) S- 11.4% 5 BV LDH1 LDH isoenzymes LDH1/LDH2 (+ or -) or Target value +/- 30% 1 CLIA, 3 NYS LDH1 Lactate dehydrogenase 1 isoform (LDH1) S- 8.2% 5 BV LDH2 Lactate dehydrogenase 2 isoform (LDH2) S- 5.7% 5 BV LDH3 LD Isoenzymes 3-5 3.00% or 30% 6 AAB LDH3 Lactate dehydrogenase 3 isoform (LDH3) S- 5.8% 5 BV
MICROGLOB a2-Macroglobulin S- 7.6% 5 BV MICROGLOB a1-Microglobulin, concentration, first m U- 43.9% 5 BV MICROGLOB a2-Microglobulin output, overnight U- 34.7% 5 BV MONO Monocytes, count B- 27.9% 5 BV MONONUC Infectious mononucleosis Target value +/- 2 dilution or (pos. or neg.) 1 CLIA MPV Mean platelet volume (MPV) 5.8% 5 BV MRNA LDL receptor mRNA S- 24.1% 5 BV MSAFP MSAFP Centaur 3 SD 4 CAP MSHCG MShCG Centaur 3 SD 4 CAP MUCIN Mucinous antigen (M S- 18.5% 5 BV